Healthcare provider profile · identity verified

Nufayl Khan, MD

Family Practice · MONROEVILLE, PA · NPI 1376804468

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	948	289
Amlodipine Besylate	Amlodipine Besylate	414	132
Lisinopril	Lisinopril	357	115
Metformin Hcl	Metformin Hcl	246	77
Levothyroxine Sodium	Levothyroxine Sodium	238	77
Omeprazole	Omeprazole	199	53
Hydrochlorothiazide	Hydrochlorothiazide	185	61
Rosuvastatin Calcium	Rosuvastatin Calcium	182	60
Losartan Potassium	Losartan Potassium	160	50
Metoprolol Succinate	Metoprolol Succinate	158	54
Pantoprazole Sodium	Pantoprazole Sodium	152	40
Famotidine	Famotidine	133	43
Alendronate Sodium	Alendronate Sodium	129	38
Gabapentin	Gabapentin	127	34
Metoprolol Tartrate	Metoprolol Tartrate	127	40
Furosemide	Furosemide	126	41
Fluticasone Propionate	Fluticasone Propionate	117	43
Metformin Hcl Er	Metformin Hcl	116	42
Simvastatin	Simvastatin	109	36
Glipizide Er	Glipizide	106	32
Duloxetine Hcl	Duloxetine Hcl	100	20
Escitalopram Oxalate	Escitalopram Oxalate	92	28
Albuterol Sulfate Hfa	Albuterol Sulfate	88	29
Eliquis	Apixaban	88	22
Carvedilol	Carvedilol	84	20
Tamsulosin Hcl	Tamsulosin Hcl	81	28
Allopurinol	Allopurinol	77	23
Ozempic	Semaglutide	77	16
Atenolol	Atenolol	76	19
Ezetimibe	Ezetimibe	73	30
Clopidogrel	Clopidogrel Bisulfate	68	24
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	60	51
Hydralazine Hcl	Hydralazine Hcl	60	19
Sertraline Hcl	Sertraline Hcl	60	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	60	16
Trazodone Hcl	Trazodone Hcl	59	21
Buspirone Hcl	Buspirone Hcl	56	15
Tramadol Hcl	Tramadol Hcl	52	suppressed
Lorazepam	Lorazepam	51	13
Warfarin Sodium	Warfarin Sodium	51	13
Valsartan	Valsartan	50	16
Venlafaxine Hcl Er	Venlafaxine Hcl	50	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	11
Synthroid	Levothyroxine Sodium	48	15
Bupropion Xl	Bupropion Hcl	46	15
Meloxicam	Meloxicam	43	11
Potassium Chloride	Potassium Chloride	43	13
Alprazolam	Alprazolam	41	15
Finasteride	Finasteride	40	13
Jardiance	Empagliflozin	40	15
Spironolactone	Spironolactone	39	15
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Donepezil Hcl	Donepezil Hcl	35	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	33	16
Montelukast Sodium	Montelukast Sodium	33	suppressed
Temazepam	Temazepam	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Baclofen	Baclofen	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	23
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	23
Ibuprofen	Ibuprofen	24	suppressed
Bumetanide	Bumetanide	23	12
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Prednisone	Prednisone	22	14
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Naproxen	Naproxen	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Cephalexin	Cephalexin	18	14
Memantine Hcl	Memantine Hcl	18	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	12
Valacyclovir	Valacyclovir Hcl	17	suppressed
Folic Acid	Folic Acid	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Irbesartan	Irbesartan	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Brilinta	Ticagrelor	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Dilt-Xr	Diltiazem Hcl	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Jentadueto	Linagliptin/Metformin Hcl	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Prolia	Denosumab	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Sulfasalazine	Sulfasalazine	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Tymlos	Abaloparatide	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Pentasa	Mesalamine	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Emgality Pen	Galcanezumab-Gnlm	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Oxazepam	Oxazepam	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error